- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.25 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x BGC- XYS- XYS: alpha-D-xylopyranose-(1-3)-alpha-D-xylopyranose-(1-3)-beta-D-glucopyranose
- 9 x CA: CALCIUM ION(Non-covalent)
- 1 x FUC: alpha-L-fucopyranose(Post Translational Modification)
- 10 x TMA: TETRAMETHYLAMMONIUM ION(Non-covalent)(Non-functional Binders)
TMA.11: 7 residues within 4Å:- Chain A: K.62, D.63, Q.64
- Chain C: Q.110, P.111, T.112, P.206
1 PLIP interactions:1 interactions with chain A- Salt bridges: A:D.63
TMA.14: 5 residues within 4Å:- Chain B: V.55, H.64, E.68, Q.69, S.70
1 PLIP interactions:1 interactions with chain B- pi-Cation interactions: B:H.64
TMA.15: 4 residues within 4Å:- Chain B: L.61, S.62, E.63, H.64
1 PLIP interactions:1 interactions with chain B- pi-Cation interactions: B:H.64
TMA.16: 3 residues within 4Å:- Chain B: D.177, V.214, G.215
No protein-ligand interaction detected (PLIP)TMA.17: 4 residues within 4Å:- Chain B: F.126, N.149, Y.175, K.180
1 PLIP interactions:1 interactions with chain B- pi-Cation interactions: B:F.126
TMA.18: 4 residues within 4Å:- Chain B: I.53, S.70, R.71, R.72
No protein-ligand interaction detected (PLIP)TMA.19: 4 residues within 4Å:- Chain C: T.172, E.174, F.175, L.176
1 PLIP interactions:1 interactions with chain C- Salt bridges: C:E.174
TMA.20: 10 residues within 4Å:- Chain A: V.92
- Chain B: R.119, F.123
- Chain C: T.35, Q.37, S.47, Y.51, F.76, Y.78, P.92
1 PLIP interactions:1 interactions with chain C- pi-Cation interactions: C:F.76
TMA.21: 7 residues within 4Å:- Chain C: K.68, Y.103, V.146, F.147, G.148, K.149, D.150
1 PLIP interactions:1 interactions with chain C- Salt bridges: C:D.150
TMA.22: 3 residues within 4Å:- Chain C: Q.114, S.115, T.126
No protein-ligand interaction detected (PLIP)- 1 x 0Z7: N-acetyl-D-phenylalanyl-N-[(2S,3S)-6-carbamimidamido-1-chloro-2-hydroxyhexan-3-yl]-L-phenylalaninamide(Covalent)
0Z7.13: 25 residues within 4Å:- Chain B: C.26, H.41, C.42, G.85, T.86, T.87, K.165, D.181, S.182, C.183, K.184, G.185, D.186, S.187, V.205, S.206, W.207, G.208, Q.209, G.210, C.211, A.212, G.218, V.219, Y.220
15 PLIP interactions:15 interactions with chain B- Hydrophobic interactions: B:V.205, B:W.207
- Hydrogen bonds: B:S.182, B:S.182, B:K.184, B:G.185, B:S.187, B:S.206, B:G.208, B:G.208, B:G.210, B:G.210, B:G.210
- Water bridges: B:W.207
- Salt bridges: B:D.181
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sorensen, A.B. et al., Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa. J.Biol.Chem. (2020)
- Release Date
- 2019-12-11
- Peptides
- Coagulation factor VII: A
Coagulation factor VII: B
Tissue factor: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
LB
HC
T
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.25 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x BGC- XYS- XYS: alpha-D-xylopyranose-(1-3)-alpha-D-xylopyranose-(1-3)-beta-D-glucopyranose
- 9 x CA: CALCIUM ION(Non-covalent)
- 1 x FUC: alpha-L-fucopyranose(Post Translational Modification)
- 10 x TMA: TETRAMETHYLAMMONIUM ION(Non-covalent)(Non-functional Binders)
- 1 x 0Z7: N-acetyl-D-phenylalanyl-N-[(2S,3S)-6-carbamimidamido-1-chloro-2-hydroxyhexan-3-yl]-L-phenylalaninamide(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Sorensen, A.B. et al., Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa. J.Biol.Chem. (2020)
- Release Date
- 2019-12-11
- Peptides
- Coagulation factor VII: A
Coagulation factor VII: B
Tissue factor: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
LB
HC
T